Biomaterial Database

Increased cyclosporine bioavailability from a microemulsion formulation in a liver transplant recipient. 1994

I S Sketris, and V McAlister, and M R Wright

UI	MeSH Term	Description	Entries
D008297	Male		Males
D004339	Drug Compounding	The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814).	Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D004655	Emulsions	Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES.	Emulsion
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D001682	Biological Availability	The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.	Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D016031	Liver Transplantation	The transference of a part of or an entire liver from one human or animal to another.	Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D016572	Cyclosporine	A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).	Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

I S Sketris, and V McAlister, and M R Wright

Absorption of cyclosporine (Neoral) from a microemulsion formulation in a living donor liver transplant recipient.

November 2002, Transplantation proceedings,

I S Sketris, and V McAlister, and M R Wright

Cyclosporin absorption from microemulsion formulation in liver transplant recipient.

February 1993, Lancet (London, England),

I S Sketris, and V McAlister, and M R Wright

Improved cyclosporine bioavailability in black pediatric liver transplant recipients after administration of the microemulsion formulation.

March 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,

I S Sketris, and V McAlister, and M R Wright

Bile-independent absorption of cyclosporine from a microemulsion formulation in liver transplant patients.

September 1995, Transplantation,

I S Sketris, and V McAlister, and M R Wright

Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.

August 1996, Transplantation proceedings,

I S Sketris, and V McAlister, and M R Wright

Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.

August 1998, Transplantation proceedings,

I S Sketris, and V McAlister, and M R Wright

Improved absorption and bioavailability of cyclosporine A from a microemulsion formulation in lung transplant recipients affected with cystic fibrosis.

August 1997, Transplantation proceedings,